1007-3418
2015 Issue 7
Holistic integrative hepatology
Fan Daiming;
Fan Daiming;
..............page:481-482
Noninvasive tests for staging and prognostication of chronic liver diseases: technical innovationtranslates into clinical application
You Hong;,Ou Xiaojuan;,Ma Hong;,Kong Yuanyuan;,Jia Jidong;
You Hong;,Ou Xiaojuan;,Ma Hong;,Kong Yuanyuan;,Jia Jidong;
..............page:483-484
Commentary on key recommendations and guidelines development methodology of World Health Organization guideline for prevention, care and treatment of persons with chronic hepatitis B infection
Kong Yuanyuan;,You Hong;,Jia Jidong;,Zhang Lan;
Kong Yuanyuan;,You Hong;,Jia Jidong;,Zhang Lan;
..............page:485-487
Key points of 2015 EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis
wang zuo ;, wang min ;, zhao wen zuo ;, shi zuo zuo ;, sun ya zuo ;, wu xiao ning ;, you hong ;, jia ji dong ;
wang zuo ;, wang min ;, zhao wen zuo ;, shi zuo zuo ;, sun ya zuo ;, wu xiao ning ;, you hong ;, jia ji dong ;
..............page:488-492
Comparison of combined immunization schemes influence on anti-HBs of babies born to mothers with high-load hepatitis B virus infection
Wang Cuimin;,Han Guorong;,Jiang Hongxiu;,Kan Naiying;,Wang Yan;,Shi Jinmei;
Wang Cuimin;,Han Guorong;,Jiang Hongxiu;,Kan Naiying;,Wang Yan;,Shi Jinmei;
..............page:493-497
Clinical significance of high-sensitivity C-reactive protein in development of chronic hepatitis B
ma li na ;, liu xiao yan ;, hu yan chao ;, zuo xia ;, tang zuo zuo ;, pan jin liang ;, liu shuai wei ;, ding xiang chun ;
ma li na ;, liu xiao yan ;, hu yan chao ;, zuo xia ;, tang zuo zuo ;, pan jin liang ;, liu shuai wei ;, ding xiang chun ;
..............page:498-501
Correlation studies between real-time shear wave elastography measuring liver stiffness and the degree of esophageal varices
Wang Jinhuan;,Yu Guoying;,Xu Huixiong;,Ding Yuehe;,Ding Ruihua;,Zu Hongmei;
Wang Jinhuan;,Yu Guoying;,Xu Huixiong;,Ding Yuehe;,Ding Ruihua;,Zu Hongmei;
..............page:502-506
Validation study of prediction models of hepatitis B virus-related hepatocellular carcinoma
chen zuo ;, chen jing ;, zheng zuo ;, dong zuo ;, you jia ;, yuan ping ;, zhu yue yong ;, liu yu rui ;, jiang jia zuo ;
chen zuo ;, chen jing ;, zheng zuo ;, dong zuo ;, you jia ;, yuan ping ;, zhu yue yong ;, liu yu rui ;, jiang jia zuo ;
..............page:507-511
Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B
zhang yuan qing ;, peng li jun ;, cao yi zuo ;, zeng zhi ping ;, wu yu zuo ;, shi hong ;, chen shi yao ;, guo jin sheng ;
zhang yuan qing ;, peng li jun ;, cao yi zuo ;, zeng zhi ping ;, wu yu zuo ;, shi hong ;, chen shi yao ;, guo jin sheng ;
..............page:512-516
Imaging findings and transarterial therapy of primacy hepatic carcinoma fed by right renal capsular artery
Luo Jiamin;,Luo Xiaoping;,Liu Xi;,He Mingju;,Yang Wei;
Luo Jiamin;,Luo Xiaoping;,Liu Xi;,He Mingju;,Yang Wei;
..............page:517-521
Preparation of antibodies against phosphorylated YB-1 and investigation of the clinical value as a biomarker to monitor hepatocellular carcinoma with pulmonary metastasis
nie hong ;, shi jing ;, wang zuo ;, mai li ;, zhao qing ;, hu qin ;, chen wei xian ;, li pu ;
nie hong ;, shi jing ;, wang zuo ;, mai li ;, zhao qing ;, hu qin ;, chen wei xian ;, li pu ;
..............page:522-526
MiR-211 promotes invasion of hepatoma cells by targeting estrogen receptor α
Yan Yan;,Wang Qin;,Li Wei;,Li Xu;,Kan Pengcheng;,Liu Mengyuan;
Yan Yan;,Wang Qin;,Li Wei;,Li Xu;,Kan Pengcheng;,Liu Mengyuan;
..............page:527-532
Age-and, education-corrected number connection test and digit symbol test in diagnosis of minimal hepatic encephalopathy
Hao Liangcheng;,Hu Yangqian;,Hou Xiaohua;
Hao Liangcheng;,Hu Yangqian;,Hou Xiaohua;
..............page:533-537
Clinical analysis of 9 cases of liver failure with hemophagocytic syndrome
Li Juan;,Yu Hongwei;,Liu Haixia;,Zhu Yueke;,Wang Jinhuan;,Yao Qinwei;,Meng Qinghua;
Li Juan;,Yu Hongwei;,Liu Haixia;,Zhu Yueke;,Wang Jinhuan;,Yao Qinwei;,Meng Qinghua;
..............page:538-539
Indocyanine green clearance test assessment of liver reserve function and estimation of prognosis in patients with cirrhosis and liver failure
Qin Hua;,Wan Hong;,Wu Xiaoqing;,Wang Wenzheng;,Wang Zhanlan;
Qin Hua;,Wan Hong;,Wu Xiaoqing;,Wang Wenzheng;,Wang Zhanlan;
..............page:540-542
Hepatitis B virus X protein and methylation of the E-cadherin promoter in hepatocellular carcinoma
Xiong Lijuan;,Liu Yanan;,Xiong Qixiang;
Xiong Lijuan;,Liu Yanan;,Xiong Qixiang;
..............page:543-546
Inhibitory effect of mesima reishi UE-1 on biological behavior of human hepatic carcinoma cells in vitro
zhang hai ying ;, he zuo ;, lin lin ;, ma cao ;, li jing xuan ;, li hang ;, li yu lin ;, he xu ;
zhang hai ying ;, he zuo ;, lin lin ;, ma cao ;, li jing xuan ;, li hang ;, li yu lin ;, he xu ;
..............page:547-549
Portal vein thrombosis in cirrhosis: new insights into pathogenesis and diagnosis
Tang Wen;,Jia Jidong;
Tang Wen;,Jia Jidong;
..............page:550-552
MicroRNAs in biliary diseases
Chen Yihao;,Yang Liyuan;,Liu Haiying;
Chen Yihao;,Yang Liyuan;,Liu Haiying;
..............page:553-556
Progress of diffusion weighted imaging based on monoexponential and biexponential models as a clinical application for hepatic disease
Lu Guoguo;,Wang Sijia;,Gao Xuemei;
Lu Guoguo;,Wang Sijia;,Gao Xuemei;
..............page:557-560
..............page:后插2-后插4